Gene Predictis
Gene Predictis is a Swiss company at the forefront of precision medicine, developing and commercializing innovative, clinically relevant diagnostic tools based on genetics. Their mission is to improve drug treatment efficacy, reduce harmful side effects, enhance nutrition and lifestyle, and prevent disease development through validated knowledge and proprietary algorithms. They operate state-of-the-art authorized testing laboratories in Switzerland and have received prestigious awards for their contributions to precision medicine.
Industries
Nr. of Employees
small (1-50)
Gene Predictis
EPFL Innovation Park, Bâtiment B, 1015 Lausanne, Switzerland
Products
Clinically validated genetic thrombosis‑risk test
A CE‑IVD labeled genetic test that combines genetic markers and clinical factors to assess risk of thrombosis associated with hormonal contraception.
Pharmacogenetic multi-variant panel
A genotyping panel covering dozens to over a hundred clinically relevant variants in drug metabolism genes to evaluate risk of adverse drug reactions and guide prescribing.
Nutrigenetic analysis panel
A genetic and nutritional science report to optimize diet and lifestyle based on individual genetic predispositions.
Physician web portal for genotype‑guided prescribing
Interactive web tool that incorporates genotyping results and pharmacological knowledge to optimize prescription choices and flag drug–drug interactions.
Clinically validated genetic thrombosis‑risk test
A CE‑IVD labeled genetic test that combines genetic markers and clinical factors to assess risk of thrombosis associated with hormonal contraception.
Pharmacogenetic multi-variant panel
A genotyping panel covering dozens to over a hundred clinically relevant variants in drug metabolism genes to evaluate risk of adverse drug reactions and guide prescribing.
Nutrigenetic analysis panel
A genetic and nutritional science report to optimize diet and lifestyle based on individual genetic predispositions.
Physician web portal for genotype‑guided prescribing
Interactive web tool that incorporates genotyping results and pharmacological knowledge to optimize prescription choices and flag drug–drug interactions.
Services
Laboratory-based testing services using DNA/RNA technologies for germline and somatic analyses, provided to physicians and healthcare institutions.
Genotyping panels and interpretation services to assess drug metabolism and adverse reaction risk, coupled with a physician-facing portal for genotype-guided prescribing.
Genetic and nutritional analysis to inform personalized dietary and lifestyle recommendations.
Pre-therapy pharmacogenetic and somatic mutation testing, BRCA sequencing and NGS cancer panels for hereditary and somatic diagnostics.
RT‑PCR diagnostic testing for viral RNA and antibody testing (rapid lateral flow and ELISA) for detection of prior exposure.
Laboratory-based testing services using DNA/RNA technologies for germline and somatic analyses, provided to physicians and healthcare institutions.
Genotyping panels and interpretation services to assess drug metabolism and adverse reaction risk, coupled with a physician-facing portal for genotype-guided prescribing.
Genetic and nutritional analysis to inform personalized dietary and lifestyle recommendations.
Pre-therapy pharmacogenetic and somatic mutation testing, BRCA sequencing and NGS cancer panels for hereditary and somatic diagnostics.
RT‑PCR diagnostic testing for viral RNA and antibody testing (rapid lateral flow and ELISA) for detection of prior exposure.
Expertise Areas
- Clinical genetic testing
- Pharmacogenetics and medication safety
- Nutrigenetics and nutritional genomics
- Molecular oncology diagnostics
Key Technologies
- Next-generation sequencing (NGS)
- RT-PCR (reverse-transcription PCR)
- ELISA
- Lateral-flow immunoassays
News & Updates
Gene Predictis was acquired by NIMGenetics, a leading biotech company.
The company offers a range of COVID-19 tests including PCR and antibody tests.
Awarded Most Pioneering Precision Medicine Company – Europe and Best Pharmacogenetics Product – Pill Protect.
Partnership with Clinique La Prairie in longevity and wellness.
Joint distribution of Pill Protect test.
Article from AGEFI on the importance of genetic tests like CYPASS.
Gene Predictis was acquired by NIMGenetics, a leading biotech company.
The company offers a range of COVID-19 tests including PCR and antibody tests.
Awarded Most Pioneering Precision Medicine Company – Europe and Best Pharmacogenetics Product – Pill Protect.
Partnership with Clinique La Prairie in longevity and wellness.
Joint distribution of Pill Protect test.
Article from AGEFI on the importance of genetic tests like CYPASS.